Xiaohai Wang Selected Research

Xiaohai Wang Research Topics

Disease

11	Prostatic Neoplasms (Prostate Cancer) 08/2023 - 10/2012
5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2023 - 05/2012
5	Neoplasms (Cancer) 01/2022 - 10/2012
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2015
3	Tauopathies 01/2020 - 01/2017
3	Cognitive Dysfunction 01/2020 - 04/2013
2	Neoplasm Metastasis (Metastasis) 12/2020 - 06/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019 - 03/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2017 - 06/2014
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 08/2023
1	Pain (Aches) 10/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Schizophrenia (Dementia Praecox) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2019
1	Contracture 05/2019
1	Atrophy 01/2018
1	Non-Muscle Invasive Bladder Neoplasms 06/2017
1	Pathologic Processes 03/2015
1	Memory Disorders (Memory Loss) 01/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2013
1	AIDS-Related Complex (ARC) 04/2013
1	Hyperemia 01/2009
1	Tremor (Tremors) 01/2008
1	Movement Disorders (Movement Disorder) 01/2008
1	Essential Tremor (Essential Tremors) 01/2008
1	Dyskinesias (Dyskinesia) 01/2008
1	Epilepsy (Aura) 09/2006
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2004

Drug/Important Bio-Agent (IBA)

7	Androgen Receptors (Androgen Receptor)IBA 09/2018 - 05/2012
5	AndrogensIBA 08/2023 - 06/2013
4	ThuliumIBA 08/2023 - 06/2017
3	hexosaminidase CIBA 01/2020 - 01/2017
2	Endothelin-1 (Endothelin 1)IBA 11/2021 - 02/2017
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020 - 01/2020
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2017 - 03/2015
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	LigandsIBA 01/2022
1	ChemokinesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	EndoglinIBA 11/2021
1	Epidermal Growth Factor (EGF)IBA 11/2021
1	ErbB Receptors (EGF Receptor)IBA 12/2020
1	Ethanol (Ethyl Alcohol)IBA 12/2020
1	Dihydrotestosterone (Androstanolone)IBA 12/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 09/2018
1	thiamet GIBA 01/2018
1	Doxycycline (Periostat)FDA LinkGeneric 01/2018
1	TOR Serine-Threonine KinasesIBA 12/2017
1	Untranslated RNA (Noncoding RNA)IBA 04/2017
1	Hormones (Hormone)IBA 02/2017
1	Biomarkers (Surrogate Marker)IBA 03/2015
1	Muscarinic M1 ReceptorIBA 01/2015
1	Scopolamine (Hyoscine)FDA Link 01/2015
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015
1	Donepezil (Aricept)FDA LinkGeneric 01/2015
1	Cadherins (E-Cadherin)IBA 06/2014
1	CateninsIBA 06/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2013
1	InterleukinsIBA 06/2013
1	Small Interfering RNA (siRNA)IBA 06/2013
1	Interleukin-6 (Interleukin 6)IBA 06/2013
1	Eszopiclone (Lunesta)FDA Link 04/2013
1	Aminobutyrates (Aminobutyric Acid)IBA 04/2013
1	Zolpidem (Ambien)FDA LinkGeneric 04/2013
1	DORA-22IBA 04/2013
1	activity regulated cytoskeletal-associated proteinIBA 04/2013
1	monodansylcadaverineIBA 10/2012
1	Dinoprostone (PGE2)FDA Link 01/2009
1	Caffeine (No Doz)FDA LinkGeneric 01/2008
1	Adenosine A1 ReceptorIBA 01/2008
1	Purinergic P1 Receptor AntagonistsIBA 01/2008
1	Adenosine (Adenocard)FDA LinkGeneric 01/2008
1	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 08/2004
1	Purinergic P2X7 ReceptorsIBA 08/2004

Therapy/Procedure

5	Therapeutics 08/2023 - 06/2013
4	Lasers (Laser) 08/2023 - 06/2017
4	Castration 01/2022 - 06/2013
3	Drug Therapy (Chemotherapy) 01/2020 - 09/2006
1	Indwelling Catheters (Indwelling Catheter) 08/2023
1	Immunotherapy 01/2019
1	Deep Brain Stimulation 01/2008